StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
107
This month
1
This year
1
Publishing Date
2023 - 07 - 17
2
2023 - 03 - 14
3
2023 - 03 - 08
2
2023 - 01 - 06
2
2022 - 10 - 21
2
2022 - 03 - 11
2
2021 - 11 - 09
1
2021 - 11 - 04
1
2021 - 11 - 03
2
2021 - 11 - 02
1
2021 - 09 - 23
1
2021 - 09 - 20
2
2021 - 09 - 09
1
2021 - 09 - 08
2
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 24
1
2021 - 08 - 12
1
2021 - 08 - 05
1
2021 - 07 - 28
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 16
1
2021 - 06 - 11
1
2021 - 06 - 10
1
2021 - 06 - 07
1
2021 - 05 - 25
1
2021 - 05 - 11
1
2021 - 05 - 03
1
2021 - 04 - 22
1
2021 - 03 - 05
1
2021 - 03 - 02
1
2021 - 02 - 25
1
2021 - 02 - 01
1
2021 - 01 - 29
1
2021 - 01 - 19
1
2021 - 01 - 08
1
2020 - 12 - 21
1
2020 - 12 - 15
1
2020 - 11 - 04
1
2020 - 10 - 30
1
2020 - 10 - 21
1
2020 - 10 - 14
1
2020 - 09 - 24
1
2020 - 09 - 14
1
2020 - 09 - 09
1
2020 - 09 - 03
1
2020 - 08 - 31
1
2020 - 07 - 28
1
2020 - 07 - 23
1
2020 - 06 - 25
1
2020 - 06 - 24
1
2020 - 04 - 30
1
2020 - 04 - 20
1
2020 - 04 - 03
1
2020 - 03 - 26
1
2020 - 03 - 24
1
2020 - 03 - 23
1
2020 - 03 - 03
1
Sector
Agriculture, forestry, fishing and hunting
1
Finance
2
Health services
3
Health technology
107
Manufacturing
1
N/a
1
Process industries
1
Transportation and warehousing
1
Tags
Acquire
1
Acquisition
1
Aesthetic
1
Agreement
3
Antiviral
2
Application
2
Approval
1
Audio
1
Bio-nc
1
Biotech-beach
1
Calendar of events
3
Ceo
1
Ces
1
Changes in company's own shares
1
Commercialization
3
Companies
1
Company announcement
7
Conference
12
Covid
4
Covid-19
4
Derm
1
Direct
2
Directors and officers
2
Drug
2
Earnings releases and operating results
1
Enroll
4
Events
2
Fda
7
Fda acceptance
1
Financial
6
Financial results
9
Ford
2
Group
1
Health
3
In vitro
1
Life science
2
Market
2
Molluscum
9
N/a
81
Nasdaq
3
Offering
10
Pdufa
2
Pharmaceuticals
2
Phase 3
10
Positive
4
Pre-clinical
2
Preclinical
2
Presentation
4
Press releases
5
Program
3
Psoriasis
2
Publication
3
Report
7
Results
23
Sb206
5
Therapeutics
5
Treatment
10
Trial
3
Update
6
Year
2
Entities
9 meters biopharma, inc.
1
Amyris, inc.
1
Appharvest, inc.
1
Aridis pharmaceuticals inc.
1
Chain bridge i
1
Chembio diagnostics, inc.
1
Eli lilly and company
1
Heritage commerce corp
1
Latamgrowth spac
1
Ligand pharmaceuticals incorporated
4
Nabriva therapeutics plc
1
Nasdaq, inc.
1
Novan, inc.
107
Nymox pharmaceutical corporation
1
Pfizer, inc.
1
Proterra inc
1
Syneos health, inc.
3
Trevena, inc.
1
Uta acquisition corp
1
Viewray, inc.
1
Yellow corporation
1
Symbols
AAPL
1198
ABB
1433
ABBV
1030
ABLZF
1172
ABT
1797
ACN
602
AMGN
744
ARVL
4319
AVGO
597
AZN
668
BDX
796
BMY
662
BNPQF
1768
BNPQY
1768
CSCO
900
DHR
786
ERIC
1617
F
643
FNCTF
7229
FRBA
602
GE
919
GLAXF
661
GOOG
1297
GOOGL
1296
GSK
887
HON
1792
HUBS
1400
IBM
657
INTC
955
IT
595
JNJ
4606
LLY
1711
LTUM
973
LYV
717
MDT
1286
MMM
938
MS
4298
MSFT
1205
MT
592
NOK
917
NOKBF
993
NVO
636
NVS
1245
NVSEF
1035
ORCL
1161
PCRFF
651
PCRFY
651
PFE
693
PHG
963
PPRUF
1131
PPRUY
1132
SAP
1481
SAPGF
1235
SNOW
796
SNY
4559
SNYNF
3617
TEVJF
633
TMO
1630
VZ
1223
XYF
678
Exchanges
Nasdaq
107
Nyse
1
Crawled Date
2023 - 07 - 17
2
2023 - 03 - 14
3
2023 - 03 - 08
2
2023 - 01 - 06
2
2022 - 10 - 21
2
2022 - 10 - 14
1
2022 - 09 - 15
1
2022 - 08 - 11
1
2022 - 08 - 04
1
2022 - 07 - 19
1
2022 - 07 - 13
1
2022 - 06 - 13
1
2022 - 06 - 09
1
2022 - 05 - 19
1
2022 - 05 - 16
1
2022 - 05 - 06
1
2022 - 04 - 20
1
2022 - 03 - 24
1
2022 - 03 - 14
1
2022 - 03 - 11
2
2022 - 02 - 22
1
2022 - 02 - 15
1
2022 - 01 - 14
1
2021 - 11 - 12
1
2021 - 11 - 10
1
2021 - 11 - 09
1
2021 - 11 - 04
1
2021 - 11 - 03
2
2021 - 11 - 02
1
2021 - 09 - 23
1
2021 - 09 - 20
2
2021 - 09 - 09
1
2021 - 09 - 08
2
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 24
1
2021 - 08 - 12
1
2021 - 08 - 05
1
2021 - 07 - 28
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 16
1
2021 - 06 - 11
1
2021 - 06 - 10
1
2021 - 06 - 07
1
2021 - 05 - 25
1
2021 - 05 - 11
1
2021 - 05 - 03
1
2021 - 04 - 22
1
2021 - 03 - 05
1
2021 - 03 - 02
1
2021 - 02 - 25
1
2021 - 02 - 01
1
2021 - 01 - 29
1
2021 - 01 - 19
1
2021 - 01 - 08
1
2020 - 12 - 21
1
2020 - 12 - 15
1
2020 - 12 - 01
20
Crawled Time
03:00
1
11:00
6
12:00
6
12:15
2
12:20
3
12:30
1
13:00
17
13:06
1
13:15
6
13:20
11
13:30
2
14:00
8
14:01
3
14:03
2
14:05
1
14:20
2
14:30
2
15:20
1
16:00
1
20:00
5
21:00
3
21:06
1
22:13
20
23:00
2
Source
www.biospace.com
6
www.globenewswire.com
92
www.novan.com
6
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
Previous years
symbols :
NOVN
save search
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
Published:
2024-04-03
(Crawled : 14:30)
- biospace.com/
LGND
|
$70.87
1.4%
1.38%
150K
|
Health Technology
|
-4.53%
|
O:
-0.83%
H:
3.14%
C:
2.93%
pharmaceuticals
commercialization
therapeutics
Delisting of Securities of Nymox Pharmaceutical Corporation; Aridis Pharmaceuticals Inc.; Novan, Inc.; ViewRay, Inc.; 9 Meters Biopharma, Inc.; Nabriva Therapeutics plc; UTA Acquisition Corporation; AppHarvest, Inc.; Yellow Corporation; Proterra Inc.; Amyris, Inc.; Chain Bridge I; LatAmGrowth SPAC; and SpringBig Holdings, Inc. from The Nasdaq Stock Market
Published:
2023-09-07
(Crawled : 20:00)
- globenewswire.com
AMRSQ
|
$0.0015
-95.0%
35K
|
Manufacturing
|
-91.11%
|
O:
-10.0%
H:
16.05%
C:
8.64%
VRAYQ
|
$0.0001
0.0%
600
|
Manufacturing
|
-99.99%
|
O:
6.84%
H:
13.6%
C:
-4.0%
NDAQ
|
$61.51
0.69%
0.68%
2.8M
|
Finance
|
18.25%
|
O:
0.0%
H:
0.19%
C:
-0.45%
ARDS
|
$0.0635
2.82%
150K
|
Health Technology
|
-31.03%
|
O:
0.0%
H:
13.45%
C:
-12.07%
nasdaq
acquisition
pharmaceuticals
therapeutics
proterra
market
Ligand Offers $15 Million to Acquire Assets of Novan, Inc.
Published:
2023-07-17
(Crawled : 14:20)
- biospace.com/
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-84.6%
|
O:
-63.13%
H:
2.09%
C:
-20.11%
LGND
|
$70.87
1.4%
1.38%
150K
|
Health Technology
|
3.01%
|
O:
0.94%
H:
1.74%
C:
0.39%
acquire
Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection
Published:
2023-07-17
(Crawled : 13:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-84.6%
|
O:
-63.13%
H:
2.09%
C:
-20.11%
LGND
|
$70.87
1.4%
1.38%
150K
|
Health Technology
|
3.01%
|
O:
0.94%
H:
1.74%
C:
0.39%
sb206
agreement
Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Published:
2023-06-05
(Crawled : 13:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-91.67%
|
O:
2.65%
H:
4.31%
C:
-0.86%
update
meeting
Novan Focuses Strategic Direction and Announces Restructuring
Published:
2023-05-31
(Crawled : 20:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-93.08%
|
O:
-8.82%
H:
0.0%
C:
-9.68%
Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published:
2023-05-15
(Crawled : 11:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.65%
|
O:
-6.25%
H:
1.58%
C:
-3.33%
update
financial
results
Novan to Report First Quarter 2023 Financial Results on May 15, 2023
Published:
2023-05-08
(Crawled : 13:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-91.75%
|
O:
-0.88%
H:
4.42%
C:
-1.77%
report
financial
results
Novan Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement¹
Published:
2023-04-27
(Crawled : 13:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.41%
|
O:
-1.61%
H:
4.1%
C:
0.82%
rapid
psoriasis
publication
Novan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD
Published:
2023-04-20
(Crawled : 13:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.98%
|
O:
-2.24%
H:
3.05%
C:
1.53%
Novan Reports Full Year 2022 Financial Results and Provides Corporate Update
Published:
2023-03-30
(Crawled : 11:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-91.52%
|
O:
7.21%
H:
7.55%
C:
0.84%
year
update
financial
results
Novan to Report Full Year 2022 Financial Results on March 30, 2023
Published:
2023-03-23
(Crawled : 13:00)
- novan.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.41%
|
O:
0.81%
H:
0.0%
C:
-8.0%
report
year
financial
results
Novan Announces Closing of $6.0 Million Registered Direct Offering
Published:
2023-03-16
(Crawled : 21:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-91.67%
|
O:
0.0%
H:
0.88%
C:
-5.31%
direct
offering
Novan to Present at the Oppenheimer 33rd Annual Healthcare ConferencePresentation with live webcast today, March 14th at 10:40 AM ET
Published:
2023-03-14
(Crawled : 14:00)
- biospace.com/
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.09%
|
O:
-5.88%
H:
8.04%
C:
4.46%
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
Published:
2023-03-14
(Crawled : 12:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.09%
|
O:
-5.88%
H:
8.04%
C:
4.46%
conference
Novan Announces $6.0 Million Registered Direct Offering
Published:
2023-03-14
(Crawled : 12:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.09%
|
O:
-5.88%
H:
8.04%
C:
4.46%
offering
direct
Novan Moves Forward with Unified Corporate Branding
Published:
2023-03-08
(Crawled : 14:00)
- novan.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-93.03%
|
O:
4.44%
H:
0.0%
C:
-4.26%
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
Published:
2023-03-08
(Crawled : 03:00)
- novan.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-93.03%
|
O:
4.44%
H:
0.0%
C:
-4.26%
molluscum
treatment
fda
pdufa
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
Published:
2023-03-07
(Crawled : 13:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.87%
|
O:
5.3%
H:
1.44%
C:
-2.88%
molluscum
treatment
fda
pdufa
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
Published:
2023-01-18
(Crawled : 13:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.76%
|
O:
0.77%
H:
5.14%
C:
-2.29%
companies
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.